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ABSTRACT
Background: Evidence from the United States and Europe suggests that the use of prescription drugs may vary by 
ethnicity. In Canada, ethnic disparities in prescription drug use have not been as well documented as disparities in 
the use of medical and hospital care. We conducted a cross-sectional analysis of survey and administrative data to 
examine needs-adjusted rates of prescription drug use by people of different ethnic groups.
Methods: For 19 370 non-Aboriginal people living in urban areas of British Columbia, we linked data on self-identified 
ethnicity from the Canadian Community Health Survey with administrative data describing all filled prescriptions 
and use of medical services in 2005. We used sex-stratified multivariable logistic regression analysis to measure dif-
ferences in the likelihood of filling prescriptions by drug class (antihypertensives, oral antibiotics, antidepressants, 
statins, respiratory drugs and nonsteroidal anti-inflammatory drugs [NSAIDs]). Models were adjusted for age, gen-
eral health status, treatment-specific health status, socio-economic factors and recent immigration (within 10 years).
Results: We found evidence of significant needs-adjusted variation in prescription drug use by ethnicity. Compared 
with women and men who identified themselves as white, those who were South Asian or of mixed ethnicity were 
almost as likely to fill prescriptions for most types of medicines studied; moreover, South Asian men were more likely 
than white men to fill prescriptions for antibiotics and NSAIDs. The clearest pattern of use emerged among Chinese 
participants: Chinese women were significantly less likely to fill prescriptions for antihypertensives, antibiotics, anti-
depressants and respiratory drugs, and Chinese men for antidepressant drugs and statins.
Interpretation: We found some disparities in prescription drug use in the study population according to ethnic group. 
The nature of some of these variations suggest that ethnic differences in beliefs about pharmaceuticals may generate 
differences in prescription drug use; other variations suggest that there may be clinically important disparities in 
treatment use.
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F
rom 1986 to 2006, as a result of their increased 
availability, promotion and use, prescription drugs 
became the fastest growing component of Canada’s 
health care costs.
1 During that time, the ethnic compos-
ition of Canada’s population changed substantially: the 
share of the population born outside Canada rose from 
16% to 20%, and the share belonging to  “visible minor-
ities” increased from 6% to 16%.
2 Although ethnicity is a 
difficult construct to work with empirically, it an import-
ant marker of societal groupings for health care prac-
tice and policy. People of different ethnic identities may 
have different needs for, access to and even outcomes 
from health care.
3 Racial and ethnic disparities in the 
use of medical and hospital care have been documented 
in Canada and other developed countries;
4–8 however, 
disparities in prescription drug use have not been stud-
ied as thoroughly in Canada. Evidence from the United 
States and Europe suggests that prescription drug use 
may vary by race and country of birth, and Canadian 
studies have shown disparities between Aboriginal and 
non-Aboriginal populations.
9–14
With regard to the growing non-Aboriginal ethnic 
minority groups in Canada, it may not be possible, for 
a number of reasons, to extrapolate existing evidence of 
disparities in the use of health services to disparities in 
the use of prescription drugs. Because outpatient phar-
maceutical  benefits  are  not  universal  in  Canada,  dis-
parities in access to prescription drugs may exist even 
if access to primary care is relatively equitable. More-
over, ethnic differences in beliefs about pharmaceuticals 
could result in differences in the use of medicines that 
are not reflected in the use of other health services.
15 
We compared the use of prescription drugs in a 
sample of residents of different ethnic backgrounds in 
the province of British Columbia. We studied the use 
of prescription drugs from 6 therapeutic classes: anti-
hypertensives, oral antibiotics, antidepressants, statins, 
respiratory  drugs  and  nonsteroidal  anti-inflammatory 
drugs (NSAIDs). We chose these classes to reflect com-
monly used medicines (which was necessary to ensure 
sufficient statistical power in the analysis) that spanned 
a variety of therapeutic purposes. The latter criterion en-
abled us to explore the hypothesis that, owing to the in-
fluences of personal beliefs, ethnic variations in the use of 
prescription drugs will differ by the nature of treatment.
Methods
Data source. We obtained data from the 2001, 2003 and 
2005 cycles of the Canadian Community Health Sur-
vey (CCHS). Conducted in English, French or the inter-
viewee’s preferred language, the CCHS is completed by a 
randomly selected person aged 12 or older per household 
drawn from a complex sample frame.
16 For our study, 
we included data from respondents in British Colum-
bia whose CCHS data could be linked to administrative 
health care datasets maintained by Population Data BC. 
The  administrative  datasets  do  not  include  data  from 
registered  First  Nations,  veterans,  inmates  of  federal 
penitentiaries and Royal Canadian Mounted Police.
We excluded CCHS respondents in rural and mixed 
urban-rural areas, because ethnic minority groups are 
highly concentrated in urban settings and because there 
are marked urban/rural differences in the use of pre-
scription drugs in British Columbia.
17  The  addition  of 
rural  populations  (with  appropriate  controls  for  rural 
settings)  would  have  increased  only  the  sample  size 
without adding statistical power. We excluded CCHS 
respondents  who  identified  themselves  as  Aboriginal 
because their administrative health care data may have 
been incomplete and therefore may have biased results. 
To ensure comparability of data, we also excluded in-
dividuals with missing CCHS data, those who did not 
reside in British Columbia for at least 275 days in 2005 
and those who lived in areas with high rates of non–fee-
for-service medical care. The last exclusion criterion was 
necessary because our measures of health status were 
based in part on diagnoses from fee-for-service med-
ical claims data; high rates of non–fee-for-service care 
would bias these measures. (See Appendix A, online, for 
details regarding the sample selection.)
Study variables. Using the BC PharmaNet database, we 
identified all prescriptions filled by study participants 
during 2005. PharmaNet records every prescription dis-
pensed in community pharmacies and long-term care 
facilities, regardless of patient age or insurance status. 
Our primary outcome was whether an individual filled 
one or more prescriptions during 2005 for an antihyper-
tensive, an oral antibiotic, an antidepressant, a statin, a 
respiratory drug or an NSAID. (See Appendix B, online, 
for details regarding therapeutic categories.)
Our ethnicity measure was based on responses to the 
CCHS question “People living in Canada come from many 
different cultural and racial backgrounds. Are you: ...?” 
Individuals could respond yes to any of 13 ethnic groups 
read to them. We coded individuals who responded yes 
to more than one ethnic group as being of mixed ethni-
city; those who responded yes to a single ethnic group 
were assigned to one of the following categories: white; 
Chinese; South Asian; other Asian; or non-Asian, non-
white. (See Appendix C, online, for details regarding eth-
nic groupings.) We also used the CCHS data to identify Open Medicine 2011;5(2):e89
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recent  immigrants,  whom  we  defined  as  respondents 
who immigrated to Canada within 10 years of 2005 (our 
observation year).
To measure health status, we constructed aggregated 
diagnostic groups (ADGs) and expanded diagnostic clus-
ters (EDCs) based on International Classification of Dis-
eases (ICD-9 and ICD-10) codes drawn from records of 
all fee-for-services medical visits and hospital discharges 
during 2005.
18 A higher count of ADGs indicates a great-
er degree of overall clinical complexity and is predictive 
of increased likelihood of prescription drug use.
19 EDCs 
denote the diagnosis of specific clinical conditions; we 
used EDCs to identify common indications for each of the 
drug classes studied (see Appendix B, online). The EDCs 
included in each model were selected by practising phys-
icians and a clinical pharmacist for a previously published 
study of prescription drug use in British Columbia.
17
We used administrative records to construct house-
hold income quintiles based on a combination of house-
hold-specific  and  neighbourhood-level  income  data.
20 
Evidence indicates that access to public drug benefits 
does not differ by ethnic group.
21 However, to adjust for 
possible differences in access to private insurance bene-
fits, we identified all individuals living in households for 
which the family’s provincial medical premiums were 
paid through a household member’s employment. Such 
payment is an indicator of employment-related health 
benefits that often also include private drug coverage.
Statistical analysis. We computed unweighted, sex-strat-
ified multivariable logistic regressions on our outcome 
variables. Informed by models of health services util-
ization and evidence concerning prediction of pharma-
ceutical use and costs, our models included age, health 
status, income, employment-related health benefits and 
recent immigration (within 10 years). To allow for non-
linear relationships between age and the likelihood of 
filling prescriptions, we defined age using dummy vari-
ables for 10-year age groups. Findings concerning eth-
nic variations were robust to the inclusion or exclusion 
of variables that were not consistently statistically sig-
nificant, namely employment-related health benefits and 
recent immigration.
Funding and ethics approval. This study was funded 
by an operating grant from the Canadian Institutes of 
Health Research. The construction of the research data-
base was supported in part by contributions of the Brit-
ish Columbia Ministry of Health Services to the Centre 
for Health Services and Policy Research, University of 
British Columbia. The sponsors had no role in the project 
or in decisions to publish the results. The de-identified 
data were provided by Population Data BC with permis-
sion of data stewards at the British Columbia Ministry 
of Health Services and with permission of the College of 
Pharmacists of British Columbia. The study protocol was 
approved by the Behavioural Research Ethics Board of 
the University of British Columbia. 
Results
The final sample for our study included 19 370 individ-
uals (Table 1). People who identified themselves as white 
were older, wealthier, less healthy and less likely to have 
recently immigrated to Canada than people who were of 
non-white ethnic backgrounds. Respondents of mixed 
ethnicity (85% of whom replied yes to “white” and a vis-
ible minority group) were younger, wealthier and less 
likely to be a recent immigrant than those of a single eth-
nic group. 
Crude rates of diagnoses of conditions for which the 
selected drug classes are indicated varied by ethnic 
group, the largest variation being observed for diag-
noses for which antidepressants are indicated. White 
women, white men and south Asian men had the high-
est sex-specific prevalence of conditions for which anti-
hypertensives are commonly indicated. South Asian 
men had the highest prevalence of conditions for which 
antibiotics, statins, NSAIDs and respiratory drugs are 
commonly indicated. South Asian women had the high-
est prevalence of conditions for which antibiotics and 
NSAIDs  are  commonly  indicated.  Women  who  were 
in either the white or the non-Asian, non-white eth-
nic groups and men of mixed ethnicity had the highest 
prevalence of conditions for which antidepressants are 
commonly indicated. Crude rates of antihypertensive, 
antidepressant and statin use were highest among white 
women and men; crude rates of antibiotic and NSAID 
use were highest among South Asian women and men. 
Crude rates of respiratory drug use were highest among 
white women and South Asian men. After adjustment for 
age, general health status (using counts of ADGs), con-
dition-specific indications (using specific EDCs), socio-
economic factors and recent immigration, several ethnic 
differences in the use of prescription drugs remained. 
Table 2 lists adjusted odds ratios (ORs) for the likelihood 
of filling prescriptions for antihypertensives, antibiotics, 
antidepressants, statins, respiratory drugs and NSAIDS 
by ethnic group. For antihypertensive prescriptions, 
Chinese women were about half as likely as white women 
to fill them (OR 0.46, 95% confidence interval [CI] 0.32–
0.65). Chinese men were less likely than white men to fill 
antihypertensive prescriptions, although the difference Open Medicine 2011;5(2):e90
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was not significant (OR 0.74, 
95%  CI  0.52–1.06).  None  of 
the other ethnic differences 
in the odds of filling prescrip-
tions for antihypertensives 
were statistically significant. 
Chinese women and non-
Asian, non-white women had 
significantly  lower  odds  of 
filling prescriptions for anti-
biotics than white women. 
South Asian men were sig-
nificantly  more  likely  than 
white  men  to  fill  antibiotic 
prescriptions  (OR  1.57,  95% 
CI  1.16–2.12),  while  men  of 
“other Asian” background 
were  less  likely  to  fill  them 
(OR 0.67, CI 0.46–0.97). For 
antidepressant prescriptions, 
several  ethnic  groups  (most 
significantly  Chinese  women 
and men, but also other Asian 
women and men, and non-
Asian,  non-white  women) 
were  significantly  less  likely 
than white women and men 
to fill them.
For statins prescriptions, 
Chinese men were less likely 
than  white  men  to  fill  them 
(OR 0.57, 95% CI 0.39–0.84). 
Chinese women were signifi-
cantly less likely than white 
women  to  fill  prescriptions 
for respiratory medicines 
(OR 0.37, 95% CI 0.22–0.62). 
For  NSAID  prescriptions, 
South Asian women and men 
were more likely than white 
women and men to fill them 
(women:  OR  1.46,  95%  CI 
1.03–2.08; men: OR 1.61, 95% 
CI 1.13–2.31).
Interpretation
Using linked survey and ad-
ministrative data, we found 
statistically  significant  eth-
nic differences in the use of 
prescription drugs among 
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non-Aboriginal residents in urban areas of 
British Columbia, even after adjusting for age, 
health status, socio-economic factors and re-
cent immigration. Compared with respond-
ents who were white, those who were South 
Asian or of mixed ethnicity were about as 
likely to fill prescriptions for most classes of 
medicines studied; however, South Asian men 
were significantly more likely to fill prescrip-
tions for antibiotics  and  NSAIDs.  Although 
a dominant pattern is difficult to determine 
because ethnic differences in presciption 
drug use appear to vary across therapeutic 
categories, there are nevertheless some im-
portant disparities. Chinese women were less 
likely than white women to fill prescriptions 
for antihypertensives, antibiotics, antidepres-
sants and respiratory drugs. Chinese men 
were less likely than white men to fill prescrip-
tions for statins and antidepressants. Overall, 
ethnic disparities were greater among women 
than among men, which suggests that gender 
roles, relationships and institutions may mod-
ify the effects of ethnicity on patient or pro-
vider behaviour.
Although rates of prescription drug use are 
lower in British Columbia than in other prov-
inces,
22 we believe that the ethnic differences 
identified in our study are likely representa-
tive of disparities among ethnic populations 
in urban areas across Canada. Moreover, the 
results of our study are generally consistent 
with previous research from the United States 
and Europe, which showed that ethnic groups 
use prescription drugs less frequently than 
white people.
9–12 Two findings from our study 
stand out from the literature on prescription 
drug use: the increased use of antibiotics by 
South Asian men compared with white men 
and  the  increased  use  of  NSAIDs  by  South 
Asian woman and men compared with white 
women and men. However, there is evidence 
of a higher prevalence of reported pain among 
South Asian groups than among white people, 
which may explain these patterns.
23
Differences in the use of prescription drugs 
across ethnic groups may have resulted from 
differences in access to medical care,
4–8 bur-
dens of illness,
24–25 beliefs about medicines
15 
or communications with practitioners.
26 The 
pattern of findings across the drug classes we 
  Table 2: Adjusted odds ratios for the likelihood of ￿  lling prescriptions, 
by drug class and self-identi￿  ed ethnicity*
Drug class; ethnicity Women, OR (95% CI) Men, OR (95% CI)
Antihypertensives
White 1.00 (ref) 1.00 (ref)
Chinese 0.46 (0.32–0.65) 0.74 (0.52–1.06)
South Asian 0.77 (0.45–1.32) 0.71 (0.43–1.18)
Other Asian 0.85 (0.55–1.33) 1.57 (0.96–2.57)
Non-Asian, non-white 0.66 (0.38–1.13) 0.86 (0.48–1.55)
Mixed ethnicity 0.53 (0.25–1.12) 0.94 (0.43–2.06)
Antibiotics
White 1.00 (ref) 1.00 (ref)
Chinese 0.71 (0.57–0.89) 0.84 (0.67–1.05)
South Asian 1.08 (0.79–1.47) 1.57 (1.16–2.12)
Other Asian 0.90 (0.68–1.18) 0.67 (0.46–0.97)
Non-Asian, non-white 0.60 (0.42–0.87) 1.10 (0.77–1.56)
Mixed ethnicity 0.85 (0.56–1.28) 0.97 (0.60–1.58)
Antidepressants
White 1.00 (ref) 1.00 (ref)
Chinese 0.29 (0.20–0.42) 0.11 (0.04–0.28)
South Asian 0.80 (0.53–1.23) 0.94 (0.55–1.61)
Other Asian 0.31 (0.19–0.52) 0.31 (0.12–0.77)
Non-Asian, non-white 0.59 (0.37–0.94) 0.51 (0.25–1.03)
Mixed ethnicity 1.23 (0.76–1.99) 0.45 (0.19–1.09)
Statins
White 1.00 (ref) 1.00 (ref)
Chinese 0.71 (0.48–1.05) 0.57 (0.39–0.84)
South Asian 0.59 (0.29–1.19) 1.00 (0.63–1.58)
Other Asian 1.17 (0.73–1.87) 1.24 (0.74–2.06)
Non-Asian, non-white 0.60 (0.29–1.22) 1.04 (0.61–1.77)
Mixed ethnicity 1.54 (0.76–3.15) 0.52 (0.18–1.53)
Respiratory drugs
White 1.00 (ref) 1.00 (ref)
Chinese 0.37 (0.22–0.62) 0.98 (0.62–1.55)
South Asian 0.55 (0.29–1.05) 1.07 (0.61–1.88)
Other Asian 0.89 (0.52–1.51) 1.36 (0.71–2.59)
Non-Asian, non-white 0.97 (0.53–1.77) 0.93 (0.44–1.95)
Mixed ethnicity 0.83 (0.41–1.71) 0.84 (0.33–2.18)
NSAIDs
White 1.00 (ref) 1.00 (ref)
Chinese 0.78 (0.58–1.04) 0.91 (0.66–1.25)
South Asian 1.46 (1.03–2.08) 1.61 (1.13–2.31)
Other Asian 0.97 (0.68–1.38) 1.22 (0.78–1.92)
Non-Asian, non-white 1.17 (0.77–1.78) 1.19 (0.75–1.87)
Mixed ethnicity 1.20 (0.74–1.96) 1.16 (0.60–2.26)
*Models were adjusted for age (10-year age groups), general health status (aggregated diagnostic 
groups), treatment-speci￿  c indications of potential need (expanded diagnostic clusters, outlined 
in Appendix B), income quintiles, evidence of employment-related health bene￿  ts and recent 
immigration (within 10 years). NSAID = nonsteroidal anti-in￿  ammatory drug, ref = reference group.Open Medicine 2011;5(2):e92
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studied suggests that some differences may stem from 
beliefs and preferences about the use of prescription 
drugs versus other treatment options (including herbal 
medicines).
27 We found the greatest degree of ethnic vari-
ation in the use of antidepressants, a drug class for which 
cultural beliefs about health and treatment are likely to 
affect patient choices.
15 Patients of different ethnic back-
grounds who have depression or anxiety may present 
differently; immigrants to Canada may also choose to 
seek care through other sources, including importing 
medicines during visits to their country of birth.
28 It is 
potentially encouraging that differences in the use of 
antihypertensives and statins were smaller than differ-
ences in the use of other classes of drugs; nevertheless, 
there appear to be ethnic differences of potential clinical 
significance in such essential drug classes, particularly 
for Chinese people. The source of such differences may 
not be limited to patient preference: a telephone survey 
of residents in Vancouver (the largest urban area of Brit-
ish Columbia) found that Chinese immigrants to Canada 
were less likely than people of other ethnic backgrounds 
to receive patient education about heart disease from 
their health care providers.
26
Our study has limitations. Although we were able to 
link data on self-reported ethnic identities with admin-
istrative data on filled prescriptions, quantitative analy-
sis of observational data can provide only a generalized 
account of the complex personal and social dimensions 
of ethnicity.
29 Our measure of prescription drug use was 
based  on  filled  prescriptions,  with  no  guarantee  that 
the medicines were actually taken. Moreover, some pre-
scriptions may not be filled by patients owing to cost, be-
liefs or other reasons. Some of the ethnic differences in 
the use of prescription drugs in our study may therefore 
have been due to differences in the rates of prescriptions 
filled by patients, not to differences in the rates of pre-
scriptions written by practitioners.
The use of administrative data also limits diagnostic 
information to that documented during encounters for 
medical and hospital services. Our methods may there-
fore understate the level of health care needs for groups 
who experience economic, cultural or other demon-
strable barriers to health care. Given that our primary 
finding was that the use of prescription drugs was lower 
among ethnic minorities who may use fewer health ser-
vices, the bias from underreporting health care needs 
would tend to understate the extent of needs-adjusted 
ethnic disparities.
Having pooled CCHS data across multiple years, we 
were unable to use information on self-reported health 
status and health care use from the survey, because such 
measures are not time-invariant. We were, however, able 
to link data on self-reported ethnicity to administrative 
health care data that are not subject to recall or social-
desirability bias that might otherwise affect measure-
ment of health care needs and prescription drug use. 
The linkage of 3 cycles of the CCHS data to administra-
tive records produced a sample that, despite having a 
higher percentage of ethnic minorities than samples of 
the CCHS used in other studies,
8 underrepresents immi-
grants and non-white ethnic groups in British Columbia 
compared with census data.
2 A larger, linkable source of 
ethnicity data might have reduced confidence intervals 
around point estimates and thereby resulted in statis-
tical significance of ethnic variations that appeared clin-
ically important but not statistically significant in the 
present study (e.g., use of antihypertensives and statins 
by South Asian people).
Conclusion
Despite a relatively equitable system of health care fi-
nancing in Canada, there appear to be significant eth-
nic differences in prescription drug use. Some of these 
differences, such as marked variation in the use of anti-
depressants, may reflect acceptable differences resulting 
from patient preferences and beliefs; others may reflect 
unacceptable inequities in quality of care and resulting 
outcomes. Further research is needed to separate the 
former  from  the  latter.  The  differences  in  patterns  of 
prescription drug use that we observed across ethnic 
groups suggest that simple comparisons between white 
people and a single “visible minority” group should be 
avoided whenever possible in future research. Moreover, 
our sex-specific findings suggest that gender and ethni-
city interact in ways that are potentially important for 
health care practice and policy. To address these import-
ant issues with quality scientific evidence, more routine 
collection of, and research into, information concerning 
ethnicity and health care in Canada will be required.
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